Jun.01, 2016, Poland Food and Drug Administration (hereinafter referred to as SPDA) issued GMP inspection certificate: Shenzhen Techdow pharmaceutical Co,.Ltd. Pharmaceutical production was considered to comply with GMP eu directive 2003/94 / EC required, Granted by the European GMP inspection.
At Oct.2015 and Apr.2016, SPDA Inspection group Appointments by European regulators, processed site GMP inspection for API and injection production separately. Throughout the process, the specialist and reviewers carried out with strict, comprehensive, systematic by means of Field tour, Access to Information, debrief, sample survey for the inspection. During the inspection, the whole company to complete all tasks cooperated with inspection work actively. Finally, Inspection group considered that Techdow API and injection production in line with the requirements of the European GMP, and we passed the site inspection acceptance successfully.
Passing the site inspection of the European GMP is one of key Initiatives to implement the strategy targets of our company, and the result of the hard work of the whole company. It certified that our GMP management is up to the European GMP standards persistently, gained chances for the competitions in European markets and built solid foundation for the company developing.
Since the company established, the quality is as the first request in every details at work according to GMP. This is the important support of passing the Major certification inspection all the times. In the future, we will continue follow the GMP requirements, continuous improvement and contribute the creation of human health career.
Picture 1: The photo of inspection group and company representatives
Picture2: inspection certificate of EU GMP